Lords and Company Worldwide Holdings (XCNQ:LRDS) Other Financing: C$0.00 Mil (TTM As of Aug. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lords and Company Worldwide Holdings Other Financing?

Lords and Company Worldwide Holdings XCNQ:LRDS Other Financing is C$0.00 Mil as of Aug. 2023.

Lords and Company Worldwide Holdings's Other Financing for the three months ended in Aug. 2023 was C$0.00 Mil.

Lords and Company Worldwide Holdings's Other Financing for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.00 Mil.

Lords and Company Worldwide Holdings Other Financing Historical Data

* Premium members only.

The historical data trend for Lords and Company Worldwide Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lords and Company Worldwide Holdings Other Financing Chart

Lords and Company Worldwide Holdings Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Aug20 Nov21 Nov22
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.26 0.00 0.00 0.05 0.00

Lords and Company Worldwide Holdings Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lords and Company Worldwide Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of C$0.00 Mil mean?
Lords and Company Worldwide Holdings (XCNQ:LRDS) has a Other Financing of C$0.00 Mil as of Aug. 2023. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Lords and Company Worldwide Holdings and its competitors.
Is Lords and Company Worldwide Holdings' Other Financing too high?
Lords and Company Worldwide Holdings' current Other Financing is C$0.00 Mil.
How does Lords and Company Worldwide Holdings' Other Financing compare to ZTS and CTLT?
Lords and Company Worldwide Holdings' Other Financing of C$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Lords and Company Worldwide Holdings and its competitors. Lords and Company Worldwide Holdings's current Other Financing is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lords and Company Worldwide Holdings stock overvalued right now?
Lords and Company Worldwide Holdings (XCNQ:LRDS) has a current Other Financing of C$0.00 Mil. The current Other Financing is C$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Lords and Company Worldwide Holdings (XCNQ:LRDS), the current Other Financing is C$0.00 Mil as of Aug. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lords and Company Worldwide Holdings Business Description

Address 409 Granville Street, Suite 1000, Vancouver, BC, CAN, V6C 1T2
Lords and Company Worldwide Holdings Corp develops, produces, and markets lifestyle apparel and natural health products through its e-Commerce platform to retail, B2B and B2C, consumers in North America and Europe utilizing its proprietary direct-to-consumer platform. Through continuous strategic white labelling, Lords has a footprint in the nutraceutical product markets.